Astro-Med Appoints Stephen J. Russo as Director of Operational Excellence

  Astro-Med Appoints Stephen J. Russo as Director of Operational Excellence

     Brings Nearly 20 Years of Leadership Experience in Manufacturing and
                      Transactional Process Improvements

Business Wire

WEST WARWICK, R.I. -- June 25, 2014

Astro-Med, Inc. (NASDAQ: ALOT), a global leader in the manufacture, marketing
and distribution of specialized printing systems and data acquisition systems,
today announced the appointment of Stephen J. Russo as Director of Operational
Excellence.

“Stephen’s proven track record in rapidly implementing global lean
transformations makes him an ideal choice to lead our lean initiatives that
will help insure that we achieve our performance excellence goals,” said
Astro-Med Chief Executive Officer Gregory A. Woods. “Stephen understands that
creating and sustaining a lean culture requires a balanced focus on quality,
delivery, productivity and growth. He has successfully implemented lean
processes at some of the best operating companies in the world such as Avery
Dennison, Thermo Fisher Scientific, Textron and Danaher, all which share
elements in common with our core businesses. Over nearly 20 years, Stephen has
played a transformational role in lean management through the development and
implementation of kaizen events and other training tools that have produced
dramatic improvements in operational and transactional processes.”

“Astro-Med is a dynamic organization with a 45-year history of successful
product development and technology innovation, and it is with particular
excitement that I begin this new opportunity,” Russo said. “Under Greg’s
leadership, it is clear that the company is committed to a lean operating
model and over the past year the company has made substantive process
improvements in both the manufacturing and transactional areas. I look forward
to accelerating our lean transformation and supporting our growth objectives
by engaging employees across the company to deliver tactical solutions that
connect organizational strategy and operational results.”

Russo previously served for three years as Corporate Director, Lean Enterprise
for Thermo Fisher Scientific, where he was responsible for the lean
transformation of six global divisions. From 2009 to 2011 he was Director,
Global Process Transformation, Retail Information Services Division at Avery
Dennison Corporation, where he oversaw the transformation of 60 independently
run sites to globally common processes. Before that he was Corporate Lean
Sensei at Textron Corporation from 2005 to 2009. In that role he was
responsible for transforming many Textron business units from traditional
batch and queue to Lean Manufacturing. From 2002 to 2005 he served as
Corporate Director for Danaher Business Systems (DBS), where he focused on
leadership training as well as development and implementation of lean
conversion techniques. Russo also has worked as Lean Manufacturing Manager at
Rexam Beverage Can Americas and in operational excellence roles at The
Wiremold Company and United States Surgical Corp. He served as a Nuclear
Weapons Specialist in the US Air Force and received a bachelor’s degree in
productivity management from Central Connecticut University and a master’s
degree in operations management from Rensselaer Polytechnic Institute.

About Astro-Med, Inc.

Astro-Med, Inc. is a leading manufacturer of specialty high tech printing
systems and data acquisition systems. Products include color label printers
and consumables sold under the QuickLabel Systems brand as well as rugged
printers for aerospace and defense applications and data acquisition products
sold under the Astro-Med brand. Astro-Med, Inc. is a member of the Russell
Microcap® Index. Additional information is available by visiting
www.astro-medinc.com.

Forward-Looking Statements

Information included in this news release may contain forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements are not statements of historical fact, but
rather reflect our current expectations concerning future events and results.
These statements may include the use the words “believes,” “expects,”
“intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and
similar expressions to identify forward-looking statements. Such
forward-looking statements, including those concerning the appointment of
Stephen J. Russo as Director of Operational Excellence, involve risks,
uncertainties and other factors, some of which are beyond our control, which
may cause our actual results, performance or achievements to be materially
different from those expressed or implied by such forward-looking statements.
These risks, uncertainties and factors include, but are not limited to, those
factors set forth in the Company’s Annual Report on Form 10-K for the fiscal
year ended January 31, 2014 and subsequent filings Astro-Med makes with the
Securities and Exchange Commission. The Company undertakes no obligation to
publicly update or revise any forward-looking statements, whether as a result
of new information, future events or otherwise. The reader is cautioned not to
unduly rely on such forward-looking statements when evaluating the information
presented in this news release.

Contact:

Astro-Med, Inc.
Joseph O’Connell, 401-828-4000
Senior Vice President & CFO
joconnell@astromed.com
 
Press spacebar to pause and continue. Press esc to stop.